|
π¬
|
Autoimmune hepatitis: Effect of symptoms and cirrhosis on natural history and outcome
J. Feld,
H. Dinh,
T. Arenovich,
V. Marcus,
I. Wanless,
E. Heathcote
|
8 |
2005 |
8
π¬
|
|
π¦
|
Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors.
13 auth.
V. Marcus,
L. Madlensky,
R. Gryfe,
Hyeja Kim,
K. So,
A. Millar,
Larissa K. Temple,
E. Hsieh,
T. Hiruki,
S. Narod,
...
B. Bapat,
S. Gallinger,
M. Redston
|
8 |
1999 |
8
π¦
|
|
π
|
eIF4E/4E-BP ratio predicts the efficacy of mTOR targeted therapies.
14 auth.
T. Alain,
M. Morita,
B. Fonseca,
Akiko Yanagiya,
N. Siddiqui,
M. Bhat,
Domenick Zammit,
V. Marcus,
P. Metrakos,
Lucie-Anne Voyer,
...
V. Gandin,
Yi Liu,
I. Topisirovic,
N. Sonenberg
|
7 |
2012 |
7
π
|
|
π
|
The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population.
33 auth.
W. Foulkes,
I. Thiffault,
S. Gruber,
M. Horwitz,
N. Hamel,
C. Lee,
J. Shia,
A. Markowitz,
A. Figer,
E. Friedman,
D. Farber,
C. Greenwood,
J. Bonner,
K. Nafa,
T. Walsh,
...
V. Marcus,
L. Tomsho,
J. Gebert,
F. Macrae,
C. Gaff,
B. Paillerets,
P. Gregersen,
J. Weitzel,
P. gordon,
E. MacNamara,
M. King,
H. Hampel,
A. de la Chapelle,
J. Boyd,
K. Offit,
G. Rennert,
G. Chong,
N. Ellis
|
7 |
2002 |
7
π
|
|
π
|
The Modified Mayo Endoscopic Score (MMES): A New Index for the Assessment of Extension and Severity of Endoscopic Activity in Ulcerative Colitis Patients.
13 auth.
T. LobatΓ³n,
T. Bessissow,
G. De Hertogh,
B. Lemmens,
C. Maedler,
G. Van Assche,
S. Vermeire,
R. Bisschops,
P. Rutgeerts,
A. Bitton,
...
W. Afif,
V. Marcus,
M. Ferrante
|
7 |
2014 |
7
π
|
|
π¬
|
Risk of dysplasia in long-term ileal pouches and pouches with chronic pouchitis.
M. Thompson-Fawcett,
V. Marcus,
M. Redston,
Z. Cohen,
R. McLeod
|
6 |
2001 |
6
π¬
|
|
π¬
|
Deletion of the carcinoembryonic antigen-related cell adhesion molecule 1 (Ceacam1) gene contributes to colon tumor progression in a murine model of carcinogenesis
Nelly Leung,
C. Turbide,
Melanie Olson,
V. Marcus,
Serge Jothy,
N. Beauchemin
|
6 |
2006 |
6
π¬
|
|
π
|
Family history characteristics, tumor microsatellite instability and germline MSH2 and MLH1 mutations in hereditary colorectal cancer
16 auth.
B. Bapat,
L. Madlensky,
Larissa K. Temple,
Tadaaki Hiruki,
M. Redston,
D. Baron,
L. Xia,
V. Marcus,
C. Soravia,
A. Mitri,
...
Wesley Shen,
R. Gryfe,
T. Berk,
B. Chodirker,
Z. Cohen,
S. Gallinger
|
6 |
1999 |
6
π
|
|
π
|
Safety and Feasibility of Using Magnetic Resonance Imaging Criteria to Identify Patients With "Good Prognosis" Rectal Cancer Eligible for Primary Surgery: The Phase 2 Nonrandomized QuickSilver Clinical Trial.
38 auth.
E. Kennedy,
M. Ε imunoviΔ,
K. Jhaveri,
R. Kirsch,
J. Brierley,
S. Drolet,
C. Brown,
P. Vos,
W. Xiong,
T. MacLean,
S. Kanthan,
P. Stotland,
S. Raphael,
Gil Chow,
Catherine OβBrien,
...
C. Cho,
C. Streutker,
R. Wong,
S. Schmocker,
S. Liberman,
C. Reinhold,
N. Kopek,
V. Marcus,
A. Bouchard,
C. Lavoie,
S. Morin,
M. PΓ©rigny,
A. Wright,
Katerina Neumann,
S. Clarke,
N. Patil,
T. Arnason,
L. Williams,
R. McLeod,
G. Brown,
A. Mathieson,
A. Pooni,
N. Baxter
|
6 |
2019 |
6
π
|
|
π
|
Homozygous BUB1B mutation and susceptibility to gastrointestinal neoplasia.
14 auth.
T. Rio Frio,
J. Lavoie,
N. Hamel,
F. Geyer,
Y. Kushner,
D. Novak,
L. Wark,
C. Capelli,
J. Reis-Filho,
S. Mai,
...
T. Pastinen,
M. Tischkowitz,
V. Marcus,
W. Foulkes
|
6 |
2010 |
6
π
|
